What Researchers Did
This systematic review assessed the primary clinical evidence supporting hyperbaric oxygen therapy (HBOT) in the management of diabetic foot ulcers (DFUs).
What They Found
Six studies with a total of 391 patients were included, showing that HBOT generally led to reduced major amputation rates and improved ulcer healing compared to standard care. Most studies indicated decreased ulcer size and depth with HBOT, though one study found no significant differences in amputation rates or long-term wound healing.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers might benefit from hyperbaric oxygen therapy as a potential treatment option to reduce the risk of amputation and improve wound healing. However, individual patient circumstances and the availability of this specialized therapy should be discussed with their healthcare providers.
Canadian Relevance
This systematic review did not include any studies specifically conducted in Canada or with Canadian patients.
Study Limitations
The review identified variations in methodological rigor, including selection bias and insufficient blinding, across the included studies.